Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Related structures:
AlphaFold database: A0A381MJV1
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 26 | 30 | PF00656 | 0.595 |
CLV_NRD_NRD_1 | 11 | 13 | PF00675 | 0.625 |
CLV_NRD_NRD_1 | 33 | 35 | PF00675 | 0.539 |
CLV_PCSK_FUR_1 | 9 | 13 | PF00082 | 0.597 |
CLV_PCSK_KEX2_1 | 11 | 13 | PF00082 | 0.604 |
CLV_PCSK_KEX2_1 | 16 | 18 | PF00082 | 0.571 |
CLV_PCSK_KEX2_1 | 35 | 37 | PF00082 | 0.551 |
CLV_PCSK_PC1ET2_1 | 11 | 13 | PF00082 | 0.595 |
CLV_PCSK_PC1ET2_1 | 16 | 18 | PF00082 | 0.560 |
CLV_PCSK_PC1ET2_1 | 35 | 37 | PF00082 | 0.551 |
CLV_PCSK_PC7_1 | 12 | 18 | PF00082 | 0.597 |
CLV_PCSK_SKI1_1 | 25 | 29 | PF00082 | 0.593 |
CLV_PCSK_SKI1_1 | 39 | 43 | PF00082 | 0.438 |
DEG_APCC_DBOX_1 | 38 | 46 | PF00400 | 0.641 |
DOC_CYCLIN_yCln2_LP_2 | 45 | 48 | PF00134 | 0.547 |
DOC_PP1_SILK_1 | 39 | 44 | PF00149 | 0.668 |
DOC_PP2B_LxvP_1 | 45 | 48 | PF13499 | 0.547 |
DOC_USP7_MATH_1 | 58 | 62 | PF00917 | 0.623 |
DOC_USP7_UBL2_3 | 49 | 53 | PF12436 | 0.598 |
DOC_USP7_UBL2_3 | 7 | 11 | PF12436 | 0.595 |
LIG_14-3-3_CanoR_1 | 17 | 27 | PF00244 | 0.596 |
LIG_FHA_2 | 19 | 25 | PF00498 | 0.590 |
LIG_UBA3_1 | 41 | 49 | PF00899 | 0.616 |
MOD_CK2_1 | 18 | 24 | PF00069 | 0.537 |
MOD_Cter_Amidation | 32 | 35 | PF01082 | 0.599 |
MOD_Cter_Amidation | 70 | 73 | PF01082 | 0.765 |
MOD_GlcNHglycan | 60 | 63 | PF01048 | 0.652 |
MOD_GSK3_1 | 23 | 30 | PF00069 | 0.573 |
MOD_NEK2_1 | 23 | 28 | PF00069 | 0.527 |
MOD_PK_1 | 37 | 43 | PF00069 | 0.594 |
MOD_PKA_1 | 12 | 18 | PF00069 | 0.597 |
MOD_Plk_1 | 23 | 29 | PF00069 | 0.592 |
MOD_Plk_1 | 37 | 43 | PF00069 | 0.594 |
TRG_NLS_MonoCore_2 | 10 | 15 | PF00514 | 0.606 |
TRG_NLS_MonoExtC_3 | 11 | 16 | PF00514 | 0.582 |
TRG_NLS_MonoExtN_4 | 69 | 76 | PF00514 | 0.706 |
TRG_NLS_MonoExtN_4 | 9 | 16 | PF00514 | 0.586 |
TRG_Pf-PMV_PEXEL_1 | 25 | 29 | PF00026 | 0.593 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P3K4 | Leptomonas seymouri | 86% | 100% |
A0A0S4IJI0 | Bodo saltans | 69% | 81% |
A0A3Q8IBZ2 | Leishmania donovani | 100% | 100% |
A4HEL5 | Leishmania braziliensis | 88% | 100% |
C9ZS75 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 60% | 81% |
E9AXZ1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 95% | 100% |
Q4Q9I1 | Leishmania major | 96% | 100% |
V5DR93 | Trypanosoma cruzi | 68% | 80% |